Thesis
Latest round
- Series A
Last raised
- Apr 2023
Total raised
- $19M
Investors
- 7
About Thesis
, dba Thesis, operates as a provider of nootropic supplements that help users boost cognition as well as raise energy levels, feel motivated, clear brain fog, and increase focus. The company was founded by its CEO, Dan Freed.13 million post-money. The company specializes in customized nootropic compounds that stimulate specific aspects of the brain. Thesis formulates nutrient molecules and gives personalized recommendations based on individual goals and unique brain chemistry, with a focus on improving mental performance. The procedure starts with a quiz that examines individual needs and ambitions. Customers receive a beginning package including four blends to sample over the course of a month and can optimize their mixes with the help of wellness coaches and nootropics experts. The blends provided by Thesis are tailored to solve specific issues such as energy, attention, motivation, clarity, creativity, and reasoning. Thesis provides optimum bioavailability and excellent results for its consumers by utilising studied dosages and ingredients. The firm offers ingredients including choline, ginkgo biloba, theobromine, lion’s mane, agmatine, NAC, and others.
Who invested in Thesis
7 investors across 2 rounds
See all investors in Thesis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Thesis
Who invested in Thesis?
Thesis has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Thesis raised?
Thesis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Thesis last raise money?
Thesis's most recent round on record is a Series A, in Apr 2023.
What does Thesis do?
, dba Thesis, operates as a provider of nootropic supplements that help users boost cognition as well as raise energy levels, feel motivated, clear brain fog, and increase focus.
Where is Thesis headquartered?
Thesis is headquartered in New York, US.
Which VCs invest in companies like Thesis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back food companies at Thesis's stage. Their profiles are linked below.
VCs backing food startups at Series A
Raising like Thesis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.